A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants

NCT07421778 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participant Study

Interventions

DRUG: QRL-101
DRUG: Placebo

Sponsor

QurAlis Corporation